Ardelyx is a biopharmaceutical company focused on developing and commercializing first-in-class medicines aimed at significant unmet medical needs. With products like IBSRELA® and XPHOZAH®, Ardelyx utilizes innovative solutions to address critical health issues such as IBS and hyperphosphatemia, both in the U.S. and through partnerships in international markets.
